Chronic Pancreatitis. Effect of Pioglitazone on Endocrine Function, Exocrine Function & Structure, Pain & Life Quality
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if study drug (Pioglitazone) treatment will improve
pre-diabetes (insulin resistance) or ealy diabetes and improve clinical symptoms (pain) or
laboratory evidence of chronic pancreatitis.
The goal of the investigators is to gather information from this study to help gain
understanding of a potential therapy for chronic pancreatitis.
Phase:
Phase 2
Details
Lead Sponsor:
University of Michigan
Collaborators:
National Institute on Alcohol Abuse and Alcoholism (NIAAA) Takeda Pharmaceuticals North America, Inc.